BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

FDA Commissioner addresses medical product supply chain affected by COVID-19

By

By NewsDesk  @infectiousdiseasenews On Thursday, FDA Commissioner Stephen M. Hahn, M.D. addressed the issues and impact of the COVID-19 outbreak has had on the medical product supply chain: As I have...

Toxoplasmosis treatment: FDA approves generic of Daraprim

By

The U.S. Food and Drug Administration has approved an application for the first generic of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis (an infection caused by the parasite Toxoplasma...

Visceral leishmaniasis: Novartis and DNDi to jointly develop a new oral drug

By

Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, have signed a collaboration and licence agreement to jointly develop LXE408,...

Remdesivir for the treatment of COVID-19: Clinical trials begins at the University of Nebraska

By

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun...

Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds

By

Cocrystal Pharma, Inc., a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that it has entered into a license agreement with Kansas State University...

Antifungal drug, Ibrexafungerp, for the treatment of vaginal yeast infection, progresses to late stage development

By

SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that it has completed patient enrollment in its global...

Antiviral drug, Remdesivir, prevents MERS coronavirus disease in macaques

By

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes...

Brain-eating amoeba: Researchers design new compounds that show promise in the laboratory as treatments

By

Brain-eating amoebae can cause particularly harmful forms of encephalitis, and more than 95% of people who develop these rare but devastating infections die. Despite the high mortality rate, there is currently...

Rabies: New prophylactic and therapeutic avenues

By

Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people. Yet, since the first vaccine developed by Louis Pasteur more...

Antiviral drug, Remdesivir, being used for treatment of novel coronavirus

By

The investigational drug remdesivir, developed through research conducted through the Antiviral Drug Discovery and Development Center, or AD3C, and centered at the University of Alabama at Birmingham,...